Home/Companies/MedTech/Austral DX

Austral DX

France·Active·1yr hold

Entry

2025

Hold

1yr

Status

Active

Who owns Austral DX?

Austral DX is a French MedTech company, currently owned by Aloe Private Equity since 2025 and Audacia.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY

Most recent investor

Aloe Private Equity

Sorbonne Venture · 2022 · VC

2 ownership periods · full history below

Key facts

HQFrance

SectorMedTech

Websitewww.australdx.fr

Ownership history

2 ownership periods · co-invest detected

Active

Co-held by Audacia and Aloe Private Equity since 2024.

Co-invest · 2 holders · 2024 · present

2024 · present(2yr) · Sorbonne Venture by Audacia · 2020 · VC

Aloe Private EquityActive

2025 · present(1yr) · Sorbonne Venture · 2022 · VC

More from Sorbonne Venture

Other portfolio companies in the same fund.

More PE-backed in MedTech

Comparable medtech deals from other GPs.

The Carlyle Group

to Bausch + Lomb

Adicon Holdings Limited

The Carlyle Group

Francisco Partners

Alere Medical, Inc.

Alma Lasers, Ltd.

TA AssociatesIsrael

General Atlantic

Questions

Who owns Austral DX?

Austral DX is currently owned by Aloe Private Equity and Audacia, through Sorbonne Venture, since 2025.

When did Aloe Private Equity and 1 other acquire Austral DX?

Aloe Private Equity and 1 other acquired Austral DX in 2025.

Who has owned Austral DX over time?

Austral DX has been through 2 private-equity ownership periods: Audacia · via Sorbonne Venture by Audacia · since 2024; Aloe Private Equity · via Sorbonne Venture · since 2025.

Look up another firm or company

Data refreshed weekly · Sourced from public filings · Report an issue